Early Lopinavir/ritonavir does not reduce mortality in COVID-19 patients: Results of a large multicenter study

被引:6
|
作者
Lora-Tamayo, Jaime [1 ]
Maestro, Guillermo [1 ]
Lalueza, Antonio [1 ]
Rubio-Rivas, Manuel [2 ]
Villarreal Paul, Gracia [3 ]
Arnalich Fernandez, Francisco [4 ]
Beato Perez, Jose Luis [5 ]
Vargas Nunez, Juan Antonio [6 ]
Llorente Barrio, Monica [7 ]
Lumbreras Bermejo, Carlos [1 ]
机构
[1] 12 Octubre Univ Hosp, Res Inst Hosp 12 Octubre I 12 Inst, Internal Med Dept, Madrid, Spain
[2] Bellvitge Univ Hosp IDIBELL, Internal Med Dept, Lhospitalet De Llobregat, Barcelona, Spain
[3] Gregorio Maranon Univ Hosp, Internal Med Dept, Madrid, Spain
[4] La Paz Univ Hosp, Internal Med Dept, Madrid, Spain
[5] Albacete Univ Hosp Complex, Internal Med Dept, Albacete, Spain
[6] Puerta Hierro Univ Hosp, Internal Med Dept, Majadahonda, Madrid, Spain
[7] Miguel Servet Hosp, Internal Med Dept, Zaragoza, Spain
关键词
D O I
10.1016/j.jinf.2021.02.011
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:293 / 298
页数:6
相关论文
共 50 条
  • [1] Crushing lopinavir/ritonavir tablets does not result in lower exposure to lopinavir/ritonavir in adult patients with COVID-19
    Mohsenian Naghani, Shaghayegh
    Jansen, Mark M. P. M.
    Jaspers, Tessa
    Bastiaans, Diane
    Burger, David
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2023, 30 (E1) : E106 - E108
  • [2] Remdesivir versus ritonavir/lopinavir in COVID-19 patients
    Antonio Vitiello
    Francesco Ferrara
    Irish Journal of Medical Science (1971 -), 2021, 190 : 1249 - 1250
  • [4] Remdesivir versus ritonavir/lopinavir in COVID-19 patients
    Vitiello, Antonio
    Ferrara, Francesco
    IRISH JOURNAL OF MEDICAL SCIENCE, 2021, 190 (03) : 1249 - 1250
  • [5] Population pharmacokinetics of lopinavir/ritonavir in Covid-19 patients
    Alvarez, Jean Claude
    Moine, Pierre
    Davido, Benjamin
    Etting, Isabelle
    Annane, Djillali
    Larabi, Islam Amine
    Simon, Nicolas
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (03) : 389 - 397
  • [6] Population pharmacokinetics of lopinavir/ritonavir in Covid-19 patients
    Jean Claude Alvarez
    Pierre Moine
    Benjamin Davido
    Isabelle Etting
    Djillali Annane
    Islam Amine Larabi
    Nicolas Simon
    European Journal of Clinical Pharmacology, 2021, 77 : 389 - 397
  • [7] Lopinavir–ritonavir in severe COVID-19
    Hannah Stower
    Nature Medicine, 2020, 26 : 465 - 465
  • [8] Melatonin does not reduce mortality in adult hospitalized patients with COVID-19: a multicenter retrospective observational study
    Sanchez-Rico, Marina
    de la Muela, Pedro
    Herrera-Morueco, Juan J.
    Geoffroy, Pierre A.
    Limosin, Frederic
    Hoertel, Nicolas
    JOURNAL OF TRAVEL MEDICINE, 2022, 29 (03)
  • [9] Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study
    Di Castelnuovo, Augusto
    Costanzo, Simona
    Antinori, Andrea
    Berselli, Nausicaa
    Blandi, Lorenzo
    Bonaccio, Marialaura
    Bruno, Raffaele
    Cauda, Roberto
    Gialluisi, Alessandro
    Guaraldi, Giovanni
    Menicanti, Lorenzo
    Mennuni, Marco
    My, Ilaria
    Parruti, Agostino
    Patti, Giuseppe
    Perlini, Stefano
    Santilli, Francesca
    Signorelli, Carlo
    Stefanini, Giulio G.
    Vergori, Alessandra
    Ageno, Walter
    Aiello, Luca
    Agostoni, Piergiuseppe
    Al Moghazi, Samir
    Arboretti, Rosa
    Aucella, Filippo
    Barbieri, Greta
    Barchitta, Martina
    Bartoloni, Alessandro
    Bologna, Carolina
    Bonfanti, Paolo
    Caiano, Lucia
    Carrozzi, Laura
    Cascio, Antonio
    Castiglione, Giacomo
    Chiarito, Mauro
    Ciccullo, Arturo
    Cingolani, Antonella
    Cipollone, Francesco
    Colomba, Claudia
    Colombo, Crizia
    Crosta, Francesco
    Dalena, Giovanni
    Dal Pra, Chiara
    Danzi, Gian Battista
    D'Ardes, Damiano
    de Gaetano Donati, Katleen
    Di Gennaro, Francesco
    Di Tano, Giuseppe
    D'Offizi, Gianpiero
    FRONTIERS IN MEDICINE, 2021, 8
  • [10] Slower Recovery with Early Lopinavir/Ritonavir use in Pediatric COVID-19 Patients: A Retrospective Observational Study
    Wong, Carlos K. H.
    Low, Marshall C. H.
    Kwok, Ashley C. Y.
    Lui, Angel Y. C.
    Lau, Kristy T. K.
    Au, Ivan C. H.
    Xiong, Xi
    Chung, Matthew S. H.
    Kwan, Mike Y. W.
    Lau, Eric H. Y.
    Cowling, Benjamin J.
    PEDIATRIC DRUGS, 2022, 24 (03) : 269 - 280